Genus plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genus plc with three other
miscellaneous service companies in Europe:
AddLife AB
of SWEDEN
(2020
sales of 5.27 billion Swedish Kronor [US$621.35 million]
of which 61%
was LabTech),
GW Pharmaceuticals PLC
(£407.91 million [US$567.34 million]
of which 100%
was Novel Therapeutics), and
Galapagos NV
which is
based in BELGIUM
(530.26 million Euros [US$636.57 million]
).
Sales Analysis.
During the year ended June of 2020, sales at
Genus plc were £551.40 million (US$766.90 million).
This
is
an
increase of 12.9%
versus 2019, when the company's sales were £488.50 million.
This was the fourth straight year of sales growth at Genus plc.
Sales of Operating Porcine Products Development saw an increase
of
24.5% in 2020, from
£9.40 million to £11.70 million.